GlassScriptPhysician profile
Julia Brodie
NPI 1265045199
$577.65
in general payments reported to CMS, 2019-2025
11 companies · $26.13 in 2025
The $26.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.14 · 2022: $258 · 2023: $137 · 2024: $130 · 2025: $26.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $187.22 | 2022-2023 | Puraply |
| Kerecis Limited | $72.54 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Solventum Corporation | $58.95 | 2024-2025 | Activ.A.C., Promogran Prisma, Kerramax Care |
| Paratek Pharmaceuticals, INC. | $50.00 | 2024 | Nuzyra |
| Aroa Biosurgery Incorporated | $43.11 | 2022 | |
| Smith+Nephew, INC. | $41.93 | 2021-2022 | |
| Integra Lifesciences Corporation | $39.27 | 2022 | |
| Convatec INC. | $39.15 | 2023 | |
| Kci USA, INC. | $19.11 | 2022 | |
| Melinta Therapeutics, LLC | $15.21 | 2022 | |
| Hydrofera LLC | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Brodie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.